Confidential Engagement Between Activists and Boards

Before an activist investor launches a public campaign—with 13D filings, proxy fights, or media pressure—they almost always knock on the board’s door first. This confidential engagement phase is a delicate negotiation played in private, governed by strict secrecy rules, and often shaped by the threat of what might happen if talks fail.

Why the confidential phase exists

Activist investors are not movie villains who announce plans in a press release. They prefer to enter boardrooms quietly. Why? Because secrecy gives them leverage. A board surprised by an activist’s ambitions on a 13D filing has already lost the element of surprise and can prepare a defense. A board that learns the activist’s thesis in private—before they own their 5% stake legally—is caught off-guard and under pressure to negotiate quickly.

From the board’s side, a confidential meeting also signals professionalism. If an activist approaches with a credible thesis, taking the meeting shows the board of directors takes shareholder input seriously, which may defuse pressure and avoid a costly proxy fight.

For both sides, the confidential phase is a mechanism for testing whether a negotiated settlement is possible before incurring legal fees, proxy solicitation costs, and management distraction.

The mechanics: NDA and wall-crossing

When an activist approaches a company, the first document is usually a confidentiality agreement (NDA). It binds the activist (and their advisors—lawyers, consultants, and sometimes prime brokers) to keep the company’s secrets. The NDA typically covers:

• Timing and duration: information shared may be “return or destroy” after a set period (60 to 120 days), or indefinite.
• Permitted recipients: the activist may share with their lawyers and financial advisors, but usually not with other shareholders, media, or competitors.
• Trading restrictions: the activist typically agrees not to buy or sell the target’s shares while discussions are ongoing (a “wall” that limits their trading freedom).

The “wall-crossing” clause is crucial. The activist agrees not to trade based on any non-public information they receive—board strategy, earnings guidance not yet disclosed, pending M&A activity, anything shared in the boardroom. If the activist violates this, they expose themselves to insider-trading liability and civil claims from the company.

What activists learn—and cannot do with it

In confidential meetings, activists often obtain material non-public information (MNPI). They might learn:

• The board of directors has just received a recapitalization proposal that isn’t public.
• The CEO is planning a major restructuring or divestiture.
• Quarterly earnings will miss consensus, or a key contract is at risk.
• The company is exploring a strategic alternative (sale, merger, or dividend).

Once wall-crossed—that is, once they’ve learned this information under an NDA—the activist cannot act on it. They cannot buy shares ahead of an earnings miss they now know is coming. They cannot short the stock before a failed deal is announced. They cannot tell other shareholders (“my sources tell me the board is planning a big restructuring”). The information is locked behind the wall.

This creates an awkward position. An activist might learn MNPI that actually supports their case (say, the company is about to announce losses that prove their thesis correct), but they cannot trade on it or even mention it publicly until the company discloses it. The confidentiality obligation is absolute.

Leverage: The threat of escalation

The board’s primary leverage is the threat to pre-disclose. Most corporate governance rules require boards to disclose activist involvement once it becomes “reasonably likely” to be material—usually once the activist owns 5% of shares and intends to engage in control or policy contests. A board can also choose to disclose earlier.

If the board detects an activist building a position and decides to pre-disclose (“Company reveals activist investor approaches board”), the activist loses surprise and shock value. Wall Street and proxy advisors mobilize to defend or challenge the activist’s plan before they’ve even made their case publicly. Pre-disclosure is a board weapon.

The activist’s counter-leverage is reputational and financial. If the board refuses to engage seriously, the activist can escalate to a public campaign, which costs money and management time but puts pressure on the board. The credible threat of an expensive proxy fight, media campaign, and proxy-fight efforts often brings boards back to the table.

The settlement phase

Most confidential engagements end in some form of settlement. Common outcomes include:

• Board seat: The activist joins the board of directors or receives the right to nominate a director.
• Board committee roles: Activist gets a seat on the compensation, audit, or strategy committee.
• Strategic commitment: The board agrees to divest a business, increase share buybacks, change management, or pursue a specific business plan.
• Governance reforms: Adoption of majority voting, declassification, or other governance changes.
• Time-bound measurement: The activist and board agree to revisit progress in 12 months; if results are unsatisfactory, the activist may escalate.

In exchange, the activist typically agrees to a standstill clause: they will not acquire shares beyond a certain threshold, will not seek additional board seats, will not make public statements critical of the company, and will not sell shares publicly for a set period (usually 12–24 months). The standstill essentially locks both sides into the deal.

Information asymmetry and negotiating leverage

The activist’s challenge is that they often lack full information. They know the stock is cheap relative to intrinsic value, but they may not know why. The board knows operational details the activist has never seen. In confidential meetings, the activist pitches their thesis, and the board either confirms concerns are overblown (“margins are about to expand”) or concedes there is a problem.

If the activist learns the company’s problems are worse than they thought, they may escalate. If the board convinces them the company has a credible turnaround plan in motion, the activist may settle for a board seat and monitoring rights. Information discovery in the confidential phase often determines the final leverage balance.

Timing and termination

Confidential engagements have an implicit expiration. An activist cannot approach a board and remain in secret talks forever. If negotiations stall, the activist typically sets an internal deadline (30 days, 60 days) to escalate. Once the activist decides to go public—file a 13D, buy more shares, issue a press release—the confidentiality obligation remains in force, but the advantage of secrecy is gone.

The NDA usually permits the activist to disclose their position and strategy publicly once they file SEC disclosures or reach a public settlement. But MNPI learned under the wall remains confidential indefinitely or until the company discloses it.

Reputational stakes

Activists who breach NDAs face severe reputational consequences and legal liability. The activist industry is small and relational; board of directors members, executives, and proxy advisors track which activists honor commitments and which leak confidential information. A breach damages an activist’s ability to be taken seriously in future engagements.

Similarly, boards that engage in bad faith—claiming to negotiate while running a proxy defense campaign in parallel—can be exposed if confidentiality is breached. Integrity in these negotiations is costly but valuable.

See also